NDC 71839-121 – Succinylcholine Chloride
Succinylcholine Chloride 20 mg/mL · Injection, Solution · Intramuscular, Intravenous
Product NDC71839-121
Product details
- Brand name
- Succinylcholine Chloride
- Generic name
- Succinylcholine Chloride
- Labeler
- BE Pharmaceuticals Inc.
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Marketing category
- ANDA · ANDA216003
- Marketed since
- February 7, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Depolarizing Neuromuscular Blocker
Active ingredients
- Succinylcholine Chloride 20 mg/mL
Uses, dosage, side effects and warnings for Succinylcholine Chloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 71839-121-25 | 25 VIAL, MULTI-DOSE in 1 CARTON (71839-121-25) / 10 mL in 1 VIAL, MULTI-DOSE (71839-121-01) | Feb 7, 2022 |
Other Succinylcholine Chloride products
- 43066-127 Succinylcholine Chloride Dihydrate 20 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 43066-129 Succinylcholine Chloride Dihydrate 20 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 31722-981 Succinylcholine Chloride 20 mg/mL · Injection, Solution · Camber Pharmaceuticals, Inc.
- 73043-021 Succinylcholine Chloride 20 mg/mL · Injection, Solution · Devatis, Inc.
- 55150-315 Succinylcholine Chloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 65219-274 Succinylcholine Chloride Dihydrate 20 mg/mL · Injection, Solution · Fresenius Kabi USA LLC
- 65219-276 Succinylcholine Chloride Dihydrate 20 mg/mL · Injection, Solution · Fresenius Kabi USA LLC
- 63323-943 Succinylcholine Chloride 20 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 68083-450 Succinylcholine Chloride 20 mg/mL · Injection, Solution · Gland Pharma Limited
- 0404-9983 Succinylcholine Chloride 20 mg/mL · Injection, Solution · Henry Schein, Inc.
- 51662-1525 Succinylcholine Chloride 20 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 0143-9338 Succinylcholine Chloride Dihydrate 20 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.